Skip to content
Study details
Enrolling now

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

University of California, Davis
NCT IDNCT05967533ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

100

Study length

about 3.6 years

Ages

18+

Locations

1 site in CA

About this study

This trial is testing the immune effects of fermented wheat germ in patients with advanced solid tumor cancers who are being treated with standard checkpoint inhibitors. This treatment is a nutritional supplement that some claim to support cancer patients during treatment, but there's currently no evidence it has therapeutic benefits as a supplement. The goal is to see if adding fermented wheat germ to standard treatment can be helpful for these patients.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Fermented Wheat Germ Extract
PhasePhase 1

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low15%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Adverse events, Immunologic effects of FWG (Immune Correlates): assay of T cell proliferation, cytokine production and cytotoxic lymphocyte (CTL) activity

Body systems

Oncology